A biotechnological company that researches, develops and applies the regeneration of diseased organs, damaged tissues and depleted resources of the body’s immune and energy systems. It is based on the scientific discoveries of the Nobel laureates of 1990, 2002, 2007 and 2012.
Good Sels Laboratory works according to international regulations for the USA, Europe and Japan: GMP is a guarantee of absolute safety of pharmaceutical products for the patient.
The staff includes 10 medical experts: doctors, biotechnologists, honored workers and candidates of science, university lecturers with over 12 years of experience. The team has published 177 scientific articles in Ukrainian, German and British journals. The latest study is published in the international journal BMC.
Five Ukrainian patents, registered by Good Sels Laboratory, have been peer-reviewed and approved and registered by the FDA agency of the US Department of Health. Since 2012, the company has entered the global market in the development of cellular products.
